STAAR Surgical Company (STAA) Insider Trading Activity

NASDAQ$27.305+2.13 (8.46%)
Market Cap
$1.26B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
9 of 849
Rank in Industry
1 of 42

STAA Insider Trading Activity

STAA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$62,750,664
10
100
Sells
$0
0
0

Related Transactions

BROADWOOD PARTNERS, L.P.10 percent owner
10
$62.75M
0
$0
$62.75M

About STAAR Surgical Company

STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). …

Insider Activity of STAAR Surgical Company

Over the last 12 months, insiders at STAAR Surgical Company have bought $62.75M and sold $0 worth of STAAR Surgical Company stock.

On average, over the past 5 years, insiders at STAAR Surgical Company have bought $44.58M and sold $6.69M worth of stock each year.

Highest buying activity among insiders over the last 12 months: BROADWOOD PARTNERS, L.P. (10 percent owner) — $62.75M.

The last purchase of 316,017 shares for transaction amount of $5.88M was made by BROADWOOD PARTNERS, L.P. () on 2026‑03‑13.

List of Insider Buy and Sell Transactions, STAAR Surgical Company

2026-03-13PurchaseBROADWOOD PARTNERS, L.P.
316,017
0.6306%
$18.61
$5.88M
+29.96%
2026-03-12PurchaseBROADWOOD PARTNERS, L.P.
299,432
0.5957%
$18.12
$5.42M
+32.84%
2026-03-11PurchaseBROADWOOD PARTNERS, L.P.
54,764
0.1097%
$17.52
$959,558
+38.14%
2026-01-09PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
27,485
0.0554%
$22.05
$606,138
+4.79%
2026-01-08PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
3,240
0.0064%
$21.94
$71,082
+2.93%
2026-01-07PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
66,467
0.1333%
$22.00
$1.46M
+4.28%
2026-01-06PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
336,946
0.6154%
$21.62
$7.28M
+3.77%
2025-11-21PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
797,486
1.605%
$27.86
$22.22M
-15.86%
2025-11-20PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
393,382
0.7895%
$27.14
$10.68M
-13.82%
2025-11-19PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
309,132
0.6245%
$26.42
$8.17M
-10.85%
2025-04-10PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
900
0.0017%
$15.18
$13,658
+29.54%
2025-04-09PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
8,200
0.0155%
$15.08
$123,676
+26.12%
2025-04-08PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
178,127
0.3428%
$15.32
$2.73M
+31.84%
2025-04-07PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
138,054
0.2707%
$15.61
$2.16M
+22.80%
2025-04-04PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
497,631
1.0082%
$15.91
$7.92M
+22.68%
2025-04-03PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
209,535
0.4142%
$16.97
$3.56M
+11.98%
2025-04-02PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
31,780
0.0638%
$17.43
$553,925
+10.45%
2025-03-31PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
22,189
0.0445%
$17.46
$387,360
+10.15%
2025-03-28PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
8,131
0.0162%
$17.47
$142,014
+9.22%
2025-03-27PurchaseBROADWOOD PARTNERS, L.P.10 percent owner
3,620
0.0073%
$17.48
$63,294
+10.53%
Total: 391
*Gray background shows transactions not older than one year

Insider Historical Profitability

9.21%
BROADWOOD PARTNERS, L.P.
16123842
32.1551%
$405.84M17128
+9.23%
Caldwell Barry GPresident and CEO
251839
0.5022%
$6.34M41
+5.27%
BAILEY DON Mdirector
145139
0.2894%
$3.65M30
+7%
CURTIS NICHOLAS TSr. VP Sales
112990
0.2253%
$2.84M12
<0.0001%
Mason Caren LPresident & CEO
83645
0.1668%
$2.11M110
+1.38%
DUFFY DONALDdirector
54000
0.1077%
$1.36M22
+3.35%
Kaufman Charles SV.P. , General Counsel
33500
0.0668%
$843,195.0012
<0.0001%
Moore John Cdirector
21387
0.0427%
$538,310.7942
+39.87%
LOGAN MARK Bdirector
19600
0.0391%
$493,332.0040
+21.63%
Hughes RobinVice President, R&D
19575
0.039%
$492,702.75210
<0.0001%
MEIER RICHARD Adirector
18300
0.0365%
$460,611.0032
+42.69%
WEISNER AIMEE Sdirector
10864
0.0217%
$273,446.8820
<0.0001%
SCHLOTTERBECK DAVID Ldirector
10000
0.0199%
$251,700.0010
+47.13%
Butcher Arthur Cdirector
4208
0.0084%
$105,915.3610
<0.0001%
SILVERMAN LOUdirector
2924
0.0058%
$73,597.0812
<0.0001%
Lin Elizabeth Yeudirector
2855
0.0057%
$71,860.3510
<0.0001%
Zhou Lilian Yanshengdirector
2327
0.0046%
$58,570.5910
+11.37%
ROUSH JACK STEVENdirector
1000
0.002%
$25,170.0010
<0.0001%
*Gray background shows insiders who have made transactions during last year

STAA Institutional Investors: Active Positions

Increased Positions95+36.54%8M+16.1%
Decreased Positions114-43.85%7M-14.39%
New Positions43New3MNew
Sold Out Positions42Sold Out4MSold Out
Total Postitions241-7.31%52M+1.71%

STAA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Broadwood Capital Inc$319,060.0027.04%13.52M00%2025-09-30
Blackrock, Inc.$171,311.0014.52%7.26M-112,193-1.52%2025-09-30
Vanguard Group Inc$100,751.008.54%4.27M-121,644-2.77%2025-09-30
Yunqi Capital Ltd$59,001.005%2.5M+88,773+3.68%2025-09-30
State Street Corp$45,098.003.82%1.91M-91,941-4.59%2025-09-30
Balyasny Asset Management L.P.$42,799.003.63%1.81M+2MNew2025-09-30
Magnetar Financial Llc$28,423.002.41%1.2M+1MNew2025-09-30
Geode Capital Management, Llc$27,702.002.35%1.17M-18,998-1.59%2025-09-30
Goldman Sachs Group Inc$23,040.001.95%976,259+794,020+435.7%2025-09-30
Alpine Associates Management Inc.$21,549.001.83%913,087+913,087New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.